Nectar Lifesciences Ltd. - Research Center
532649 NECLIFE Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Profit before tax | -40.69 | 34.35 | -59.34 | 35.74 | 58.55 |
| Net cashflow-operating activity | 133.37 | 95.04 | 21.33 | 285.65 | 238.89 |
| Net cash used in investing activity | 52.03 | 16.64 | -28.62 | -33.14 | -26.13 |
| Netcash used in fin. activity | -185.57 | -119.38 | 11.49 | -251.86 | -201.09 |
| Net inc/dec in cash and equivlnt | -0.17 | -7.70 | 4.20 | 0.65 | 11.67 |
| Cash and equivalnt begin of year | 17.74 | 25.43 | 21.23 | 20.58 | 8.91 |
| Cash and equivalnt end of year | 17.57 | 17.74 | 25.43 | 21.23 | 20.58 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis